These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 317697)

  • 1. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].
    Hainaut J; Challan-Belval P; Haguenauer G; Pellegrin J; Allard P; Kermarec J
    Ann Med Interne (Paris); 1979; 130(11):517-21. PubMed ID: 317697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cancer patients with autologous lymphocytes pre-incubated with T.F. from long survivors.
    Fazio M; Negri L; Mastromatteo V; Pacchioni D; Calabrese F; Giacomasso S
    J Exp Pathol; 1987; 3(4):569-77. PubMed ID: 3454804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphocytes subpopulation in cancer's patients. Relationship with primitive anatomical location, histological type and clinical stage (author's transl)].
    Saiz Garcia F; Rodriguez Valverde V
    Bull Cancer; 1981; 68(1):32-9. PubMed ID: 6971668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of isolated cellular immune defect with transfer factor (author's transl)].
    Göring HD; Fiehring C; Schröder I
    Dermatol Monatsschr; 1980 Feb; 166(2):81-7. PubMed ID: 6967428
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
    Simó-Camps E; Vich JM; García Calderón PA; Bofill D; Grau A; Anguiz A; Forcadell I
    Med Clin (Barc); 1980 May; 74(10):403-7. PubMed ID: 6968012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
    Fujisawa T; Yamaguchi Y
    Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of transfer factor on the number of circulating lymphocytes in patients with spinocellular carcinoma of the cervicofacial area].
    Mastromatteo V; Negri L; Pacchioni D; Calabrese F; Giacomasso S; Fazio M
    Boll Soc Ital Biol Sper; 1987 Nov; 63(11):1043-50. PubMed ID: 3454189
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Transfer factor" in ophthalmology (author's transl)].
    Rocha H
    Klin Monbl Augenheilkd; 1977 Jul; 171(1):63-70. PubMed ID: 302878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the immune profile in bronchopulmonary cancer and its clinical significance].
    Anastasatu C; Morgenstern H; Burnea D; Păunescu E; Algeorge G; Petre A; Pruteanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):59-68. PubMed ID: 6312537
    [No Abstract]   [Full Text] [Related]  

  • 10. [T- and B-lymphocytes in bronchial cancer].
    Ruszel KB; Mierzejewska A
    Wiad Lek; 1980 Jun; 33(12):951-5. PubMed ID: 6968482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Active specific immunotherapy in patients with lung cancer following tumor removal].
    Mosienko MD; Dorfman MV; Romashko NI
    Vopr Onkol; 1987; 33(3):31-6. PubMed ID: 3494337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapeutic effects of auto-transfer-factor and iRNA in lung cancer (author's transl)].
    Deng WW
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Dec; 3(4):199-200. PubMed ID: 6170493
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
    Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
    Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
    Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The erythrocyte-rosette forming cell (E-RFC) count and results of treatment with transfer factor in herpes simplex keratitis (author's transl)].
    Xie LX
    Zhonghua Yan Ke Za Zhi; 1981 Jul; 17(4):204-7. PubMed ID: 6802605
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.
    Jain S; Thomas HC; Sherlock S
    Clin Exp Immunol; 1977 Oct; 30(1):10-5. PubMed ID: 606432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A; Thometz D; Garrison O; Hill JM
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic aspects of bronchopulmonary carcinoma].
    Dammacco F; Vacca A
    Arch Monaldi Mal Torace; 1991; 46(1-6):59-71. PubMed ID: 1669001
    [No Abstract]   [Full Text] [Related]  

  • 19. [Levamisole-induced immunitary responses in patients operated from bronchogenic carcinoma (author's transl)].
    Wipf R; Stinghe R; Girard JP
    Poumon Coeur; 1979; 35(4):189-93. PubMed ID: 504048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfer factor immunotherapy as an adjunct to surgery in lung cancer].
    Fujisawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):68-73. PubMed ID: 3892117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.